BioAtla, Inc.
BCAB- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001826892
No open-market purchases or sales by BioAtla, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.22M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding BioAtla, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 43 | 1 | 41 | −1 |
| Shares | 13.3M | 67.0K | 13.2M | −102.9K (−0.8%) |
| Value | $9.19M | $46.1K | $7.49M | −$1.65M (−18.0%) |
1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held BioAtla, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Marshall Wace, LLP | 891,580 | $508.2K | 0.00% |
| ADAR1 Capital Management, LLC | 183,107 | $104.0K | 0.01% |
| Virtu Financial LLC | 55,460 | $31.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 5,318 | $3.02K | 0.00% |
| Tucker Asset Management LLC | 500 | $284 | 0.00% |
| Avion Wealth | 490 | $0 | 0.00% |
Sold out (7)
Institutions that held BioAtla, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Tang Capital Management LLC | 1,374,076 | $945.2K |
| Citadel Advisors LLC | 274,036 | $188.5K |
| Citigroup Inc | 26,132 | $18.0K |
| NorthRock Partners, LLC | 20,783 | $14.3K |
| Two Sigma Securities, LLC | 13,761 | $9.47K |
| Group One Trading, L.P. | 1,155 | $795 |
| Barclays PLC | 183 | $126 |
Not filed for Q4 2025 yet (1)
Institutions that held BioAtla, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Sheets Smith Investment Management | 67,000 | $46.1K |